{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:55:11Z","timestamp":1761512111863,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.clon.2005.03.013","type":"journal-article","created":{"date-parts":[[2005,6,2]],"date-time":"2005-06-02T07:35:24Z","timestamp":1117697724000},"page":"332-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Phase I Study of Moderate-dose Radiation Therapy and Weekly Gemcitabine in Patients with Locally Advanced Non-small Cell Lung Cancer Not Suitable for Radical Chemoradiation Therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"B.H.","family":"Burmeister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.I.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.C.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dauth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.T.","family":"Walpole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2005.03.013_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2005.03.013_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-125-9-199611010-00003","article-title":"Chemotherapy plus radiotherapy compared to radiotherapy alone in the treatment of locally advanced unresectable, non-small cell lung cancer: a meta-analysis","volume":"125","author":"Pritchard","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clon.2005.03.013_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjc.1997.123","article-title":"A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non small cell lung cancer","volume":"75","author":"Ball","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2005.03.013_bib4","first-page":"3218","article-title":"Metabolism of 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine and radiation sensitization of human colon carcinoma cells","volume":"54","author":"Shewach","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.clon.2005.03.013_bib5","first-page":"A481","article-title":"A phase II study combining gemcitabine with radiotherapy in stage III NSCLC","volume":"7","author":"Goor","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2005.03.013_bib6","first-page":"2472","article-title":"A phase I study of gemcitabine with concurrent radiotherapy in stage III locally advanced non-small cell lung cancer","volume":"9","author":"van Putten","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2005.03.013_bib7","first-page":"470a","article-title":"Phase I\/II study of gemcitabine combined with cisplatin weekly and concurrent thoracic MV-radiotherapy for patients with stage III A\/B non small cell lung cancer (NSCLC)","volume":"19","author":"Varveris","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2005.03.013_bib8","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1200\/JCO.2002.03.054","article-title":"Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for unresectable stage IIIB non-small cell lung cancer: Cancer and Leukaemia Group Study 9431","volume":"20","author":"Vokes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2005.03.013_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0360-3016(01)01732-1","article-title":"Phase I study of twice weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer","volume":"51","author":"Blackstock","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2005.03.013_bib10","first-page":"804","article-title":"Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small cell lung cancer","volume":"20","author":"Trodella","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2005.03.013_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumours","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2005.03.013_bib12","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","volume":"Issue 4","author":"Rowell","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1016\/j.clon.2005.03.013_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0936-6555(96)80041-0","article-title":"Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status","volume":"8","author":"Macbeth","year":"1996","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2005.03.013_bib14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/S0959-8049(00)00345-2","article-title":"Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours","volume":"36","author":"van Moorsel","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2005.03.013_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00066-002-0879-x","article-title":"Combined radiotherapy and gemcitabine. Evaluation of clinical data based on experimental knowledge","volume":"178","author":"Mose","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2005.03.013_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4414\/smw.2002.09893","article-title":"Gemcitabine-related pulmonary toxicity","volume":"132","author":"Joerger","year":"2002","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.clon.2005.03.013_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.0767-3981.2003.00206.x","article-title":"Gemcitabine-induced severe pulmonary toxicity","volume":"18","author":"Barlesi","year":"2004","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:24:24Z","timestamp":1760541864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655505001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0936655505001743"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2005.03.013","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase I Study of Moderate-dose Radiation Therapy and Weekly Gemcitabine in Patients with Locally Advanced Non-small Cell Lung Cancer Not Suitable for Radical Chemoradiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2005.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}